Qube Research & Technologies LTD Haleon PLC Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Haleon PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,318,738 shares of HLN stock, worth $13.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,318,738
Previous 201,990
552.87%
Holding current value
$13.1 Million
Previous $2.14 Million
489.94%
% of portfolio
0.02%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HLN
# of Institutions
656Shares Held
420MCall Options Held
179KPut Options Held
38.9K-
Dodge & Cox San Francisco, CA179MShares$1.78 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$326 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$240 Million1.6% of portfolio
-
Wellington Management Group LLP Boston, MA15.3MShares$153 Million0.03% of portfolio
-
Morgan Stanley New York, NY9.89MShares$98.4 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $45.9B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...